venlafaxine hydrochloride

Generic: venlafaxine

Labeler: bluepoint laboratories
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name venlafaxine hydrochloride
Generic Name venlafaxine
Labeler bluepoint laboratories
Dosage Form TABLET, EXTENDED RELEASE
Routes
ORAL
Active Ingredients

venlafaxine hydrochloride 37.5 mg/1

Manufacturer
BluePoint Laboratories

Identifiers & Regulatory

Product NDC 68001-496
Product ID 68001-496_2b5c3dc6-9055-abe9-e063-6294a90af76e
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA214419
Listing Expiration 2026-12-31
Marketing Start 2021-04-30

Pharmacologic Class

Classes
norepinephrine uptake inhibitors [moa] serotonin uptake inhibitors [moa] serotonin and norepinephrine reuptake inhibitor [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 68001496
Hyphenated Format 68001-496

Supplemental Identifiers

RxCUI
808744 808748 808751 808753
UPC
0368001499040 0368001498043 0368001496049 0368001497046
UNII
7D7RX5A8MO

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name venlafaxine hydrochloride (source: ndc)
Generic Name venlafaxine (source: ndc)
Application Number ANDA214419 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 37.5 mg/1
source: ndc
Packaging
  • 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (68001-496-04)
source: ndc

Packages (1)

68001-496-04 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (68001-496-04)

Ingredients (1)

venlafaxine hydrochloride (37.5 mg/1)

Linked Drug Pages (1)

VENLAFAXINE HYDROCHLORIDE ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "2b5c3dc6-9055-abe9-e063-6294a90af76e", "openfda": {"upc": ["0368001499040", "0368001498043", "0368001496049", "0368001497046"], "unii": ["7D7RX5A8MO"], "rxcui": ["808744", "808748", "808751", "808753"], "spl_set_id": ["5efe1336-c796-4560-8110-a64c80eefb0c"], "manufacturer_name": ["BluePoint Laboratories"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (68001-496-04)", "package_ndc": "68001-496-04", "marketing_start_date": "20210430"}], "brand_name": "VENLAFAXINE HYDROCHLORIDE", "product_id": "68001-496_2b5c3dc6-9055-abe9-e063-6294a90af76e", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Norepinephrine Uptake Inhibitors [MoA]", "Serotonin Uptake Inhibitors [MoA]", "Serotonin and Norepinephrine Reuptake Inhibitor [EPC]"], "product_ndc": "68001-496", "generic_name": "venlafaxine", "labeler_name": "BluePoint Laboratories", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "VENLAFAXINE HYDROCHLORIDE", "active_ingredients": [{"name": "VENLAFAXINE HYDROCHLORIDE", "strength": "37.5 mg/1"}], "application_number": "ANDA214419", "marketing_category": "ANDA", "marketing_start_date": "20210430", "listing_expiration_date": "20261231"}